Physician profile
Daniel Alan Katz
NPI 1689627754
$983.08
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $190.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $158.54 | 2019-2020 | |
| Emd Serono, INC. | $125.29 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $120.09 | 2019-2020 | |
| Eisai INC. | $67.16 | 2019 | |
| Ironshore Pharmaceuticals INC. | $57.45 | 2019 | |
| Supernus Pharmaceuticals, INC. | $42.98 | 2019 | |
| Acorda Therapeutics, INC | $39.89 | 2019 | |
| Lundbeck LLC | $38.66 | 2019-2020 | |
| Grifols USA, LLC | $36.91 | 2019 | |
| Ge Healthcare | $32.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.35 | 2019 | |
| Livanova USA, INC. | $28.56 | 2019-2020 | |
| Zyla Life Sciences, INC. | $27.57 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $25.92 | 2020 | |
| Abbvie INC. | $22.85 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $22.19 | 2019 | |
| Travere Therapeutics, INC. | $18.69 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.03 | 2019 | |
| Csl Behring | $13.13 | 2019 | |
| Acadia Pharmaceuticals INC | $12.88 | 2020 | |
| Biogen, INC. | $12.47 | 2019 | |
| Tris Pharma INC | $11.46 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.24 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.